Literature DB >> 28368923

Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

Clare Verrill1, Asli Yilmaz, John R Srigley, Mahul B Amin, Eva Compérat, Lars Egevad, Thomas M Ulbright, Satish K Tickoo, Daniel M Berney, Jonathan I Epstein.   

Abstract

The International Society of Urological Pathology held a conference devoted to issues in testicular and penile pathology in Boston in March 2015, which included a presentation and discussion led by the testis microscopic features working group. This conference focused on controversies related to staging and reporting of testicular tumors and was preceded by an online survey of the International Society of Urological Pathology members. The survey results were used to initiate discussions, but decisions were made by expert consensus rather than voting. A number of recommendations emerged from the conference, including that lymphovascular invasion (LVI) should always be reported and no distinction need be made between lymphatic or blood invasion. If LVI is equivocal, then it should be regarded as negative to avoid triggering unnecessary therapy. LVI in the spermatic cord is considered as category pT2, not pT3, unless future studies provide contrary evidence. At the time of gross dissection, a block should be taken just superior to the epididymis to define the base of the spermatic cord, and direct invasion of tumor in this block indicates a category of pT3. Pagetoid involvement of the rete testis epithelium must be distinguished from rete testis stromal invasion, with only the latter being prognostically useful. Percentages of different tumor elements in mixed germ cell tumors should be reported. Although consensus was reached on many issues, there are still areas of practice that need further evidence on which to base firm recommendations.

Entities:  

Mesh:

Year:  2017        PMID: 28368923     DOI: 10.1097/PAS.0000000000000844

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.

Authors:  J Aparicio
Journal:  Clin Transl Oncol       Date:  2018-05-09       Impact factor: 3.405

2.  Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors?

Authors:  Maurizio Colecchia; Biagio Paolini; Giacomo Maria Pini; Laura Carpenito; Beatrice Maghini; Barbara Avuzzi; Anna Maria Paganoni; Nicola Nicolai
Journal:  Virchows Arch       Date:  2022-07-01       Impact factor: 4.064

Review 3.  Biomarkers of disease recurrence in stage I testicular germ cell tumours.

Authors:  Peter Lesko; Michal Chovanec; Michal Mego
Journal:  Nat Rev Urol       Date:  2022-08-26       Impact factor: 16.430

4.  Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.

Authors:  Lucia Manganaro; Matteo Saldari; Carlotta Pozza; Valeria Vinci; Daniele Gianfrilli; Ermanno Greco; Giorgio Franco; Maria Eleonora Sergi; Michele Scialpi; Carlo Catalano; Andrea M Isidori
Journal:  Eur Radiol       Date:  2017-08-30       Impact factor: 5.315

5.  Effects of 4% paraformaldehyde and modified Davidson's fluid on the morphology and immunohistochemistry of Xiang pig testes.

Authors:  Wei-Yong Wang; Li-Jie Meng; Yong-Jian Xu; Ting Gong; Yi Yang
Journal:  J Toxicol Pathol       Date:  2020-02-18       Impact factor: 1.628

6.  Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification.

Authors:  Mário Fontes-Sousa; João Lobo; Helena Magalhães; João Cassis; Mariana Malheiro; Sância Ramos; Rui Henrique; Ana Martins; Maria Joaquina Maurício
Journal:  BMC Urol       Date:  2020-08-20       Impact factor: 2.264

7.  Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study.

Authors:  Thomas Wagner; Birgitte Grønkær Toft; Birte Engvad; Jakob Lauritsen; Michael Kreiberg; Mikkel Bandak; Josephine Rosenvilde; Ib Jarle Christensen; Anette Pedersen Pilt; Daniel Berney; Gedske Daugaard
Journal:  BMJ Open       Date:  2019-10-31       Impact factor: 2.692

8.  Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.

Authors:  Leendert H J Looijenga; Theodorus H Van der Kwast; David Grignon; Lars Egevad; Glen Kristiansen; Chia-Sui Kao; Muhammad T Idrees
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.